ArticleScientific reports2017

Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles.

Stefan Hutzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.